Story
Chevron Options Market Prices 2.9% Post-Earnings Stock Move

Summary
Options traders are anticipating a 2.9% move in Chevron's stock price following its July 31 earnings report, according to Bloomberg data. Historically, the stock's actual post-earnings move has exceeded this implied volatility in half of the last eight quarters.
Options markets are pricing in a potential 2.9% move in either direction for Chevron Corp. (NYSE:CVX) shares following the company's upcoming earnings release on July 31, according to data compiled by Bloomberg.
This implied volatility figure is derived from options pricing and serves as a key gauge of market expectations for the stock's reaction to the quarterly results, which are due before the market opens.
Historical Performance vs. Expectations
A review of Chevron's past eight earnings announcements shows a mixed record of actual price movement compared to what the options market had predicted. The stock's actual move has surpassed the implied move in exactly four of those eight quarters, a 50% rate.
This suggests that while the options market provides a benchmark, significant surprises are not uncommon. Notable past reactions include:
Ad- May 1, 2026: The stock moved 1.6%, which was below the implied move of 2.4%.
- January 30, 2026: Shares jumped 6.1%, significantly exceeding the 2.0% move traders had priced in.
- August 2, 2024: The stock saw its largest recent post-earnings move, falling 5.7% against an implied volatility of just 2.5%.
What It Means for Investors
The 2.9% implied move sets a baseline for investors and traders heading into the report. A stock price change smaller than this threshold could suggest that Chevron's financial results and forward-looking guidance were largely in line with Wall Street's consensus expectations.
Conversely, a move exceeding 2.9% would signal a significant surprise, either positive or negative, that has forced the market to quickly re-evaluate the company's valuation. Investors will be closely watching metrics like production volumes, refining margins, and capital expenditure plans to determine the catalyst for the stock's ultimate reaction.
Read next
More on Stocks
Oura IPO Sees Demand Outstrip Supply by Four Times, Report Says
The health and fitness technology company's initial public offering is attracting significant investor interest, with orders reportedly reaching four times the shares available as it seeks to raise up to $2.2 billion.

Insurance Firm Fidelis Partnership Files for US Initial Public Offering
Insurance firm TFP Group, which operates as the Fidelis Partnership, has filed for an initial public offering in the U.S., setting the stage for a public listing amid a challenging market for new issues.

S&P Cuts Cable One's Credit Rating to 'B+' on Fierce Broadband Competition
S&P Global Ratings has lowered Cable One's issuer credit rating, citing intense pressure from fiber and fixed wireless rivals that is eroding the company's profitability and market share.

Mirum Pharma Gains as Investors Await FDA Ruling on Rare Disease Drug
Shares of Mirum Pharmaceuticals rose in Monday trading as the company approaches a key regulatory decision from the U.S. Food and Drug Administration for its drug candidate, zilurgisertib, which treats an ultra-rare bone disease.